SARS-CoV-2 ORF3a protein (ORF3a)

The SARS-CoV-2 ORF3a protein is the largest and most abundantly expressed accessory protein of SARS-CoV-2. It is a membrane-associated protein with 275 amino acids, typically forming homodimers or tetramers. Structurally, it possesses three hydrophobic transmembrane domains anchored in the host membrane, with both termini facing the cytoplasm. ORF3a plays essential roles in virus egress via lysosomal deacidification and inactivation, facilitating viral release. Previously classified as a viroporin (ion channel), recent data demonstrate that ORF3a does not act as an ion channel but is instead a water-permeable channel that inactivates lysosomes, blocks autophagy, and disrupts protein trafficking, thereby aiding immune evasion, cell death induction, and pathogenesis. ORF3a continues to evolve, and mutations in the domain affect its structure and function, with possible implications for COVID-19 severity and viral fitness.

Other names

SARS-CoV-2 accessory protein ORF3aOpen Reading Frame 3a proteinviroporin ORF3a

Drug mechanisms proposed in literature include blockade or modulation of the water channel activity, inhibition of protein-protein interactions (e.g., with VPS39), and suppression of the pro-inflammatory signaling pathways initiated by ORF3a. However, these remain theoretical or early-phase investigational approaches based on the protein’s newly clarified water transport and trafficking functions